phentolamine has been researched along with 2019 Novel Coronavirus Disease in 4 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukherjee, T | 1 |
| Behl, T | 1 |
| Sharma, S | 1 |
| Sehgal, A | 1 |
| Singh, S | 1 |
| Sharma, N | 1 |
| Mathew, B | 1 |
| Kaur, J | 1 |
| Kaur, R | 1 |
| Das, M | 1 |
| Aleya, L | 1 |
| Bungau, S | 1 |
| Alnomasy, SF | 1 |
| Alotaibi, BS | 1 |
| Aldosari, ZM | 1 |
| Mujamammi, AH | 1 |
| Alzamami, A | 1 |
| Anand, P | 1 |
| Akhter, Y | 1 |
| Khan, FR | 1 |
| Hasan, MR | 1 |
| Boesing, M | 1 |
| Abig, K | 1 |
| Brändle, M | 1 |
| Brutsche, M | 1 |
| Burri, E | 1 |
| Frye, BC | 1 |
| Giezendanner, S | 1 |
| Grutters, JC | 1 |
| Haas, P | 1 |
| Heisler, J | 1 |
| Jaun, F | 1 |
| Leuppi-Taegtmeyer, AB | 1 |
| Lüthi-Corridori, G | 1 |
| Müller-Quernheim, J | 1 |
| Nüesch, R | 1 |
| Pohl, W | 1 |
| Rassouli, F | 1 |
| Leuppi, JD | 1 |
| Auld, SC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS: A Randomized, Placebo Controlled, Multicenter Trial[NCT04536350] | Phase 2 | 132 participants (Anticipated) | Interventional | 2021-05-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phentolamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Anticipated pharmacological role of Aviptadil on COVID-19.
Topics: COVID-19; Drug Combinations; Humans; Phentolamine; SARS-CoV-2; Vasoactive Intestinal Peptide | 2022 |
1 trial available for phentolamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Topics: Adult; COVID-19; Drug Combinations; Humans; Multicenter Studies as Topic; Phentolamine; Randomized C | 2022 |
2 other studies available for phentolamine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
Topics: COVID-19; Drug Combinations; Humans; Phentolamine; SARS-CoV-2 | 2023 |
Aviptadil for COVID-19: A Case Study and Call to Action About the Challenges of Research During a Global Pandemic.
Topics: COVID-19; Drug Combinations; Humans; Pandemics; Phentolamine; Vasoactive Intestinal Peptide | 2022 |